Association of SSTR2 polymorphisms and glucose homeostasis phenotypes: The insulin resistance atherosclerosis family study

Diabetes

Volumn 58, Issue 6, 2009, Pages 1457-1462

  Sutton, Beth S ^a   Palmer, Nicholette D ^a   Langefeld, Carl D ^a   Xue, Bingzhong ^a   Proctor, Alexandria ^a   Ziegler, Julie T ^a   Haffner, Steven M ^b   Norris, Jill M ^c   Bowden, Donald W ^a,d  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; SOMATOSTATIN RECEPTOR 2;

ADULT; AGED; ARTICLE; FAMILY STUDY; FEMALE; GENE; GENE LOCUS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SSTR2 GENE;

ADULT; ALGORITHMS; ATHEROSCLEROSIS; FAMILY; FEMALE; GLUCOSE; HISPANIC AMERICANS; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, SOMATOSTATIN;

EID: 66649084617     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db08-0189     Document Type: Article

References (23)

1. Patel YC. Somatostatin and its receptor family. Front Neuroendocrinol 1999;20:157-198
2. Yamada Y, Post SR, Wang K, Tager HS, Bell GI, Seino S. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc Natl Acad Sci U S A 1992;89:251-255
3. Rossowski WJ, Coy DH. Potent inhibitory effects of a type four receptor-selective somatostatin analog on rat insulin release. Biochem Biophys Res Commun 1993;197:366-371 (Pubitemid 24034580)
4. Strowski MZ, Parmar RM, Blake AD, Schaeffer JM. Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice. Endocrinology 2000;141:111-117 (Pubitemid 32260349)
5. Moldovan S, Atiya A, Adrian TE, Kleinman RM, Lloyd K, Olthoff K, Imagawa D, Shevlin L, Coy D, Walsh J, et al. Somatostatin inhibits B-cell secretion via a subtype-2 somatostatin receptor in the isolated perfused human pancreas. J Surg Res 1995;59:85-90
6. Cheng H, Yibchok-anun S, Coy DH, Hsu WH. SSTR2 mediates the somatostatin-induced increase in intracellular Ca(2+) concentration and insulin secretion in the presence of arginine vasopressin in clonal beta-cell HIT-T15. Life Sci 2002;71:927-936
7. Sutton BS, Langefeld CD, Campbell JK, Haffner SM, Norris JM, Scherzinger AL, Wagenknecht LE, Bowden DW. Genetic mapping of a 17q chromosomal region linked to obesity phenotypes in the IRAS family study. Int J Obes (Lond) 2006;30:1433-1441 (Pubitemid 44306527)
8. Norris JM, Langefeld CD, Scherzinger AL, Rich SS, Bookman E, Beck SR, Saad MF, Haffner SM, Bergman RN, Bowden DW, Wagenknecht LE. Quantitative trait loci for abdominal fat and BMI in Hispanic-Americans and African-Americans: the IRAS Family study. Int J Obes Relat Metab Disord 2005;29:67-77 (Pubitemid 40065467)
9. Henkin L, Bergman RN, Bowden DW, Ellsworth DL, Haffner SM, Langefeld CD, Mitchell BD, Norris JM, Rewers M, Saad MF, Stamm E, Wagenknecht LE, Rich SS. Genetic epidemiology of insulin resistance and visceral adiposity: the IRAS Family Study design and methods. Ann Epidemiol 2003;13:211-217 (Pubitemid 36390342)
10. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev 1985;6:45-86
11. Bergman RN. Lilly lecture 1989: toward physiological understanding of glucose tolerance: minimal-model approach. Diabetes 1989;38:1512-1527 (Pubitemid 20006675)
12. Buetow KH, Edmonson M, MacDonald R, Clifford R, Yip P, Kelley J, Little DP, Strausberg R, Koester H, Cantor CR, Braun A. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc Natl Acad Sci U S A 2001;98:581-584 (Pubitemid 32105085)
13. O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998;63:259-266 (Pubitemid 30428342)
14. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet 2005;37:1217-1223
15. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265 (Pubitemid 40202029)
16. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-130
17. Hardin JW: Generalized Estimating Equations. New York, Chapman & Hall/CRC, 2003
18. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998;62:1198-1211 (Pubitemid 28199022)
19. Sutton AJ, Abrams KR, Sheldon TA, Song F: Methods for Meta-Analysis in Medical Research. West Sussex, U.K., John Wiley & Sons, 2000
20. Yuen KC, Dunger DB. Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults. Diabetes Obes Metab 2007;9:11-22 (Pubitemid 44921037)
21. Petersenn S, Rasch AC, Presch S, Beil FU, Schulte HM. Genomic structure and transcriptional regulation of the human somatostatin receptor type 2. Mol Cell Endocrinol 1999;157:75-85 (Pubitemid 29505129)
22. Pscherer A, Dorflinger U, Kirfel J, Gawlas K, Ruschoff J, Buettner R, Schule R. The helix-loop-helix transcription factor SEF-2 regulates the activity of a novel initiator element in the promoter of the human somatostatin receptor II gene. Embo J 1996;15:6680-6690 (Pubitemid 26413800)
23. Torrisani J, Hanoun N, Laurell H, Lopez F, Maoret J, Souque A, Susini C, Cordelier P, Buscail L. Identification of an upstream promoter of the human somatostatin receptor hSSTR2, that is controlled by epigenetic modifications. Endocrinology 2008;149:3137-3147